Issued Patents All Time
Showing 26–50 of 161 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10577353 | 5-(n-[6,5]-fused bicyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication | John F. Kadow, B. Narasimhulu Naidu, Zhiwei Yin, Zhongxing Zhang | 2020-03-03 |
| 10570253 | Preparation method for polymer and applications thereof | Qianping Ran, Jiaping Liu, Jianfeng Ma, Shuai Qi, Shimin Fan +1 more | 2020-02-25 |
| 10570108 | Substituted benzofuran compounds for the treatment of hepatitis C | Zhiwei Yin, John F. Kadow | 2020-02-25 |
| 10556964 | Bispecific antibody-mediated cancer therapy with cytokine-induced killer cell | Pengfei Zhou, Liu Hu, Mi Huang, Lijuan Fang, Yang Liu | 2020-02-11 |
| 10407410 | Pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication | John F. Kadow, B. Narasimhulu Naidu, Manoj Patel, Michael A. Walker, Zhiwei Yin +2 more | 2019-09-10 |
| 10391113 | Compatible composition containing chinese medicine cichorium glandulosum boiss et hout as lipid-lowering active ingredient | Jing Shang, Lin Ding, Guohong Qin, Jun Liu, Yu-Han Li +1 more | 2019-08-27 |
| 10392352 | Etomidate derivative and intermediate, preparation method and use thereof | Qingeng Li, Lingguo Zeng, Guisheng Zhang, Xiangqing Xu, Liang Ren | 2019-08-27 |
| 10323237 | Lysozyme having improved enzymatic activity | Chun-Chi Chen, Jian-Wen Huang, Rey-Ting Guo | 2019-06-18 |
| 10280183 | Therapeutic agent for treating tumors | Iwao Ojima, Jacob Vineberg | 2019-05-07 |
| 10258572 | Pharmaceutical compositions of goserelin sustained release microspheres | Wei Sun, Xuemei Zhang, Guangyi Leng, Kaoxiang Sun, Youxin Li +1 more | 2019-04-16 |
| 10239851 | Carboxylic acid derivatives and use thereof in the preparation of prodrugs | Qingeng Li, Gang Chen, Yuanzhong Wang, Wei Mao, Tong Wu +1 more | 2019-03-26 |
| 10214534 | Substituted 2-phenyl (AZA)benzofuran compounds for the treatment of hepatitis C | Zhongxing Zhang, Kyle E. Parcella, Kyle J. Eastman, John F. Kadow | 2019-02-26 |
| 10214516 | 5-(N-fused tricyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication | John F. Kadow, B. Narasimhulu Naidu, Zhiwei Yin, Zhongxing Zhang | 2019-02-26 |
| 10202403 | Macrocyclic benzofuran compounds for the treatment of hepatitis C | Zhongxing Zhang, John F. Kadow | 2019-02-12 |
| 10189816 | Substituted pyridines as inhibitors of human immunodeficiency virus replication | Kyle J. Eastman, John F. Kadow, Kyle E. Parcella, B. Narasimhulu Naidu, Zhiwei Yin +1 more | 2019-01-29 |
| 10144706 | Compounds useful as immunomodulators | Kap-Sun Yeung, Katharine A. Grant-Young, Juliang Zhu, Mark G. Saulnier, David B. Frennesson +7 more | 2018-12-04 |
| 10138256 | MK2 inhibitors and uses thereof | Matthew D. Alexander, Joseph McDonald, Yike Ni, Deqiang Niu, Russell C. Petter +3 more | 2018-11-27 |
| 10131645 | Benzofurans substituted with primary benzamide as HCV inhibitors | Zhiwei Yin, John F. Kadow | 2018-11-20 |
| 10125137 | Benzofurans substituted with bicyclic secondary benzamide as HCV inhibitors | Zhiwei Yin, John F. Kadow | 2018-11-13 |
| 10125111 | Benzofuran compounds for the treatment of hepatitis C | Zhiwei Yin, Zhongxing Zhang, John F. Kadow | 2018-11-13 |
| 10087167 | Benzofurans substituted with secondary benzamide as HCV inhibitors | Zhiwei Yin, John F. Kadow | 2018-10-02 |
| 10029014 | Synthesis of novel asymmetric bow-tie PAMAM dendrimer-based conjugates for tumor-targeting drug delivery | Iwao Ojima, Yu-Han Teng | 2018-07-24 |
| 9994578 | Benzodiazepine derivative and use thereof | Qingeng Li, Jianyong Xie, Guisheng Zhang, Xiangqing Xu | 2018-06-12 |
| 9969732 | Tetrahydroisoquinoline estrogen receptor modulators and uses thereof | Sharada Labadie, Jun Liang, Daniel Fred Ortwine, Maia Vinogradova, Xiaojing Wang +2 more | 2018-05-15 |
| 9957278 | Furopyridine compounds for the treatment of hepatitis C | Kyle J. Eastman, Zhongxing Zhang, Kyle E. Parcella, John F. Kadow | 2018-05-01 |